Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?
Read More Pharma Industry News FDA approves Genentech’s Xolair for food allergies: A new horizon in allergy treatment The U.S. Food and Drug Administration (FDA) has approved Xolair (omalizumab) for reducing allergic reactions, including anaphylaxis, that… byPallavi MadhirajuFebruary 17, 2024